We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
101
Bank of America
BAC
$436B
$942K 0.08%
24,852
+3,877
+18% +$133K
VEA icon
102
Vanguard FTSE Developed Markets ETF
VEA
$238B
$922K 0.08%
18,383
-112
-0.6% -$5.41K
PEP icon
103
PepsiCo
PEP
$193B
$919K 0.08%
5,252
+1,198
+30% +$202K
VSS icon
104
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12.1B
$916K 0.08%
7,838
– –
MA icon
105
Mastercard
MA
$521B
$900K 0.08%
1,869
+434
+30% +$198K
JNJ icon
106
Johnson & Johnson
JNJ
$646B
$893K 0.08%
5,648
+1,290
+30% +$205K
BX icon
107
Blackstone
BX
$107B
$865K 0.08%
6,582
+5
+0.1% +$624
IX icon
108
ORIX
IX
$42.4B
$842K 0.07%
+38,215
New +$777K
XOM icon
109
ExxonMobil
XOM
$644B
$823K 0.07%
7,077
+2,253
+47% +$236K
HMC icon
110
Honda
HMC
$41.3B
$812K 0.07%
21,799
+14,896
+216% +$512K
GWW icon
111
W.W. Grainger
GWW
$61.5B
$804K 0.07%
790
+23
+3% +$21.4K
VTV icon
112
Vanguard Morningstar Value ETF
VTV
$192B
$777K 0.07%
4,772
– –
SAP icon
113
SAP
SAP
$256B
$756K 0.07%
3,877
+1,831
+89% +$325K
TSM icon
114
TSMC
TSM
$2.17T
$751K 0.07%
5,517
-2,782
-34% -$346K
AMGN icon
115
Amgen
AMGN
$234B
$745K 0.07%
2,622
+116
+5% +$33.9K
VIG icon
116
Vanguard Dividend Appreciation ETF
VIG
$113B
$742K 0.07%
4,063
– –
CSCO icon
117
Cisco
CSCO
$433B
$716K 0.06%
14,344
+2,921
+26% +$146K
NVS icon
118
Novartis
NVS
$292B
$699K 0.06%
7,226
+2,598
+56% +$266K
LOW icon
119
Lowe's Companies
LOW
$117B
$695K 0.06%
2,728
+1,280
+88% +$294K
DIS icon
120
Walt Disney
DIS
$187B
$690K 0.06%
5,639
+1,759
+45% +$184K
EPD icon
121
Enterprise Products Partners
EPD
$84.3B
$682K 0.06%
23,386
+705
+3% +$19.4K
CRM icon
122
Salesforce
CRM
$211B
$669K 0.06%
2,222
+640
+40% +$185K
VT icon
123
Vanguard Total World Stock ETF
VT
$81.2B
$664K 0.06%
6,006
+3
+0% +$317
BIIB icon
124
Biogen
BIIB
$32.3B
$656K 0.06%
3,041
+223
+8% +$52.2K
SQSP
125
DELISTED
Squarespace, Inc.
SQSP
$648K 0.06%
17,788
– –
3 4
5
6 7

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.